Lack of antiviral activity of darunavir against SARS-CoV-2

OBJECTIVES: Given the high need and the absence of specific antivirals for treatment of COVID-19 (the disease caused by severe acute respiratory syndrome-associated coronavirus-2 [SARS-CoV-2]), human immunodeficiency virus (HIV) protease inhibitors are being considered as therapeutic alternatives. M...

Descripción completa

Detalles Bibliográficos
Autores principales: De Meyer, Sandra, Bojkova, Denisa, Cinatl, Jindrich, Van Damme, Ellen, Buyck, Christophe, Van Loock, Marnix, Woodfall, Brian, Ciesek, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258847/
https://www.ncbi.nlm.nih.gov/pubmed/32479865
http://dx.doi.org/10.1016/j.ijid.2020.05.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258847/
https://www.ncbi.nlm.nih.gov/pubmed/32479865
http://dx.doi.org/10.1016/j.ijid.2020.05.085

Ejemplares similares